Impax Asset Management Group Portfolio holdings
AUM
$17.4B
1-Year Return
13.12%
This Quarter Return
+7.03%
1 Year Return
+13.12%
3 Year Return
+65.42%
5 Year Return
+126.12%
10 Year Return
–
AUM
$24.9B
AUM Growth
+$947M
(+4%)
Cap. Flow
-$485M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
27.59%
Holding
403
New
12
Increased
141
Reduced
152
Closed
15
Top Buys
| 1 |
Aecom
ACM
|
$129M |
| 2 |
Aptiv
APTV
|
$101M |
| 3 |
Xylem
XYL
|
$94.4M |
| 4 |
TE Connectivity
TEL
|
$66.6M |
| 5 |
Mettler-Toledo International
MTD
|
$56.5M |
Top Sells
| 1 |
Globe Life
GL
|
$143M |
| 2 |
Pentair
PNR
|
$118M |
| 3 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
$114M |
| 4 |
Agilent Technologies
A
|
$95.4M |
| 5 |
Equinix
EQIX
|
$83.3M |
Sector Composition
| 1 | Industrials | 31.29% |
| 2 | Technology | 23.68% |
| 3 | Healthcare | 13.87% |
| 4 | Materials | 6.47% |
| 5 | Financials | 6.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Neurocrine Biosciences
NBIX
$14.3B
| $18.9M | 0.08% |
200,000
| – | – |
|
|
AAMI
127
Acadian Asset Management Inc.
AAMI
$1.59B
| $18.3M | 0.07% |
873,818
| – | – |
|
128
Bristol-Myers Squibb
BMY
$96B
| $18.3M | 0.07% |
285,577
-402,674
| -59% | -$25.8M |
|
129
Edison International
EIX
$21B
| $17.7M | 0.07% |
254,908
+2,097
| +0.8% | +$146K |
|
130
Healthcare Realty
HR
$6.35B
| $17.1M | 0.07% |
906,352
+146,707
| +19% | +$2.77M |
|
131
Gates Industrial
GTES
$6.68B
| $16.5M | 0.07% |
1,227,713
+175,000
| +17% | +$2.36M |
|
132
Belden
BDC
$5.14B
| $16.5M | 0.07% |
172,500
-17,500
| -9% | -$1.67M |
|
133
Huron Consulting
HURN
$2.44B
| $16.5M | 0.07% |
194,000
+54,000
| +39% | +$4.59M |
|
134
Johnson & Johnson
JNJ
$430B
| $16.1M | 0.06% |
97,425
+924
| +1% | +$153K |
|
135
Onto Innovation
ONTO
$5.1B
| $16M | 0.06% |
137,557
| – | – |
|
136
Coca-Cola
KO
$292B
| $15.9M | 0.06% |
264,808
+2,011
| +0.8% | +$121K |
|
137
Option Care Health
OPCH
$4.72B
| $15.4M | 0.06% |
475,000
+75,000
| +19% | +$2.44M |
|
138
General Mills
GIS
$27B
| $14.5M | 0.06% |
189,600
-1,126
| -0.6% | -$86.4K |
|
139
Eli Lilly
LLY
$652B
| $14.5M | 0.06% |
30,889
+79
| +0.3% | +$37K |
|
140
Health Catalyst
HCAT
$238M
| $14.4M | 0.06% |
1,154,475
-50,000
| -4% | -$625K |
|
141
Starbucks
SBUX
$97.1B
| $14.1M | 0.06% |
141,953
-454,039
| -76% | -$45M |
|
142
Workiva
WK
$4.48B
| $13.8M | 0.06% |
136,086
| – | – |
|
143
Cardinal Health
CAH
$35.7B
| $13.8M | 0.06% |
145,744
-39,642
| -21% | -$3.75M |
|
144
Celanese
CE
$5.34B
| $13.7M | 0.05% |
117,949
-3,199
| -3% | -$370K |
|
145
Enovis
ENOV
$1.84B
| $13.5M | 0.05% |
210,630
| – | – |
|
146
Clorox
CLX
$15.5B
| $13.3M | 0.05% |
83,476
+241
| +0.3% | +$38.3K |
|
147
lululemon athletica
LULU
$19.9B
| $13.3M | 0.05% |
35,055
-5,768
| -14% | -$2.18M |
|
148
Best Buy
BBY
$16.1B
| $13.1M | 0.05% |
160,279
-2,654
| -2% | -$217K |
|
149
Ulta Beauty
ULTA
$23.1B
| $13M | 0.05% |
27,719
+3,386
| +14% | +$1.59M |
|
150
Elevance Health
ELV
$70.6B
| $12.3M | 0.05% |
27,705
-1,779
| -6% | -$790K |
|